Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Avalon GloboCare stock

Own Avalon GloboCare stock in just a few minutes.

Fact checked

Avalon GloboCare Corp is a medical care facilities business based in the US. Avalon GloboCare shares (AVCO) are listed on the NASDAQ and all prices are listed in US Dollars. Avalon GloboCare employs 7 staff and has a trailing 12-month revenue of around USD$1.4 million.

How to buy shares in Avalon GloboCare

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Avalon GloboCare. Find the stock by name or ticker symbol: AVCO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Avalon GloboCare reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Avalon GloboCare, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Avalon GloboCare. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Avalon GloboCare share price

Use our graph to track the performance of AVCO stocks over time.

Avalon GloboCare shares at a glance

Information last updated 2021-02-24.
52-week rangeUSD$0.5 - USD$2.1935
50-day moving average USD$1.2967
200-day moving average USD$1.274
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.187

Buy Avalon GloboCare shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Avalon GloboCare stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Avalon GloboCare financials

Revenue TTM USD$1.4 million
Gross profit TTM USD$284,137
Return on assets TTM -83.33%
Return on equity TTM -259.17%
Profit margin 0%
Book value $0.066
Market capitalisation USD$106.6 million

TTM: trailing 12 months

Shorting Avalon GloboCare shares

There are currently 1.1 million Avalon GloboCare shares held short by investors – that's known as Avalon GloboCare's "short interest". This figure is 15.8% down from 1.3 million last month.

There are a few different ways that this level of interest in shorting Avalon GloboCare shares can be evaluated.

Avalon GloboCare's "short interest ratio" (SIR)

Avalon GloboCare's "short interest ratio" (SIR) is the quantity of Avalon GloboCare shares currently shorted divided by the average quantity of Avalon GloboCare shares traded daily (recently around 389867.0212766). Avalon GloboCare's SIR currently stands at 2.82. In other words for every 100,000 Avalon GloboCare shares traded daily on the market, roughly 2820 shares are currently held short.

However Avalon GloboCare's short interest can also be evaluated against the total number of Avalon GloboCare shares, or, against the total number of tradable Avalon GloboCare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Avalon GloboCare's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Avalon GloboCare shares in existence, roughly 10 shares are currently held short) or 0.0394% of the tradable shares (for every 100,000 tradable Avalon GloboCare shares, roughly 39 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Avalon GloboCare.

Find out more about how you can short Avalon GloboCare stock.

Avalon GloboCare share dividends

We're not expecting Avalon GloboCare to pay a dividend over the next 12 months.

Have Avalon GloboCare's shares ever split?

Avalon GloboCare's shares were split on a 1:4 basis on 18 October 2016. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avalon GloboCare shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Avalon GloboCare shares which in turn could have impacted Avalon GloboCare's share price.

Avalon GloboCare share price volatility

Over the last 12 months, Avalon GloboCare's shares have ranged in value from as little as $0.5 up to $2.1935. A popular way to gauge a stock's volatility is its "beta".

AVCO.US volatility(beta: 0.5)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avalon GloboCare's is 0.5033. This would suggest that Avalon GloboCare's shares are less volatile than average (for this exchange).

Avalon GloboCare overview

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. It also develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. In addition, the company develops proprietary diagnostic and therapeutic products leveraging exosome technology; and provides development services for hospitals. The company has a strategic partnership with Weill Cornell Medical College to co-develop bio-production and standardization procedures for chimeric antigen receptor (CAR)-T Therapy; GensKey Medical Technology Co. Ltd. to co-develop and commercialize point-of-care, rapid detection antibody tests to identify whether a patient has been exposed to and has developed antibodies against SARS-CoV-2; GE Healthcare to enhance standardized automation and bio-production for cellular medicines; and HydroPeptide, LLC to co-develop and commercialize various clinical-grade, exosome-based cosmeceutical and orthopedic products, as well as research agreement with Massachusetts Institute of Technology to develop CAR technology. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site